Dolby Laboratories, Inc. DLB R3K
Company Overview
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Why Investors Should Care
Maintains a net profit margin of 16.7%.
Offers a dividend yield of 2.31%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $1.35B (+5.9% YoY); net profit $255.02M.
- Trailing 12 Months Year-on-year growth — revenue -3.3%, earnings -37.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.5%, profit CAGR 1.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 4.48% |
| 1 Year: | -3.30% |
Compounded Profit Growth
| 5 Years: | 1.46% |
| 1 Year: | -37.50% |
Stock Price Performance
| 1 Year: | -13.51% |
| 6 Months: | -3.30% |
| 3 Months: | +16.06% |
| 1 Month: | +1.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)58.04 · Neutral
P/E of 26.52 is above the sector median of 26.00 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DLB Dolby Laboratories, Inc. R3K | 62.32 | 26.52 | $3.70B | 2.31% | 9.50% | 8.76% | 4.48% | 1.46% |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Jan 2016 | Apr 2016 | Jul 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Apr 2022 | Jul 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 299.53M | 299.72M | 214.78M | 240.57M | 302.38M | 338.26M | 302.16M | 298.83M | 291.88M | 351.81M | 246.91M | - | 389.87M | 319.56M | 286.80M | 351.63M | 334.37M | 289.58M | 334.92M | 375.89M | 298.37M | 315.57M | 364.52M | 288.82M | 357.00M | 369.56M | 315.55M | 307.02M | 346.71M | 395.63M | 305.00M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 44.00M | 39.52M | 43.21M | 44.73M | 40.32M |
| Gross Profit | 207.37M | 211.05M | 249.97M | 252.97M | 202.78M | 236.30M | 240.50M | 273.54M | 212.81M | 268.63M | 268.69M | 180.40M | 209.31M | 263.75M | 301.68M | 262.47M | 252.87M | 254.56M | 314.99M | 217.02M | 228.73M | 354.57M | 287.18M | 255.16M | 318.92M | 298.86M | 253.63M | 300.47M | 334.84M | 256.86M | 283.51M | 325.75M | 253.16M | 316.23M | 333.72M | 271.54M | 267.50M | 303.50M | 350.90M | 264.68M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 224.45M | 231.70M | 230.87M | 235.77M | 226.41M |
| Operating Income | - | 39.19M | 82.33M | 81.19M | - | 66.07M | 63.28M | 95.93M | - | 93.95M | 84.60M | -7.61M | - | 68.67M | 102.93M | 34.26M | - | 48.59M | 105.94M | 34.14M | - | 164.75M | 83.19M | 56.09M | 90.58M | 43.35M | 45.57M | 94.09M | 109.22M | 15.94M | 66.22M | 108.97M | 36.78M | 79.88M | 107.76M | 47.09M | 35.80M | 72.63M | 115.13M | 38.27M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.49M | 60.38M | 99.44M | 141.98M | 63.34M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.52M | 41.67M | 71.60M | 119.70M | 43.80M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.97M | -7.99M | 17.92M | 24.25M | 14.59M |
| Net Income | 46.55M | 30.90M | 67.40M | 63.63M | 23.93M | 53.37M | 50.59M | 76.04M | 21.80M | -53.30M | 65.22M | 3.12M | 26.72M | 98.22M | 73.44M | 39.57M | 43.92M | 48.75M | 88.50M | 67.28M | 26.83M | 135.20M | 76.22M | 54.62M | 80.01M | 36.72M | 39.60M | 79.38M | 95.70M | 16.40M | 66.98M | 97.83M | 38.44M | 67.82M | 91.79M | 46.07M | 49.33M | 53.33M | 94.92M | 28.60M |
| Diluted EPS | 0.45 | 0.30 | 0.66 | 0.62 | 0.23 | 0.51 | 0.49 | 0.73 | 0.21 | -0.52 | 0.61 | 0.03 | 0.25 | 0.93 | 0.70 | 0.38 | 0.43 | 0.47 | 0.86 | 0.66 | 0.26 | 1.30 | 0.73 | 0.52 | 0.77 | 0.36 | 0.39 | 0.82 | 0.98 | 0.17 | 0.69 | 1.01 | 0.40 | 0.70 | 0.94 | 0.48 | 0.51 | 0.55 | 0.99 | 0.30 |
| R&D Expense | - | 53.33M | 52.09M | 54.98M | - | 57.52M | 58.34M | 59.63M | - | 56.44M | 59.49M | 60.36M | - | 58.65M | 58.62M | 60.41M | - | 57.65M | 60.09M | 59.58M | - | 63.77M | 65.81M | 62.09M | 68.82M | 67.42M | 62.86M | 64.45M | 67.95M | 68.70M | 67.03M | 62.49M | 65.50M | 66.64M | 61.71M | 65.98M | - | 69.08M | 63.65M | 65.75M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 640.23M | 719.50M | 922.71M | 961.07M | 933.01M | 909.67M | 960.18M | 970.64M | 1.03B | 1.08B | 1.05B | 1.24B | 1.16B | 1.28B | 1.25B | 1.30B | 1.27B | 1.35B |
| Gross Profit | 572.45M | 654.74M | 790.90M | 849.89M | 840.99M | 812.96M | 890.00M | 875.82M | 916.76M | 961.65M | 927.04M | 1.08B | 1.02B | 1.15B | 1.11B | 1.15B | 1.13B | 1.19B |
| Operating Income | 286.78M | 363.67M | 429.38M | 429.73M | 361.99M | 245.26M | 273.72M | 213.23M | 231.79M | 247.13M | 183.50M | 257.08M | 218.74M | 344.39M | 206.60M | 215.75M | 258.33M | 264.96M |
| Net Income | 199.46M | 242.99M | 283.45M | 309.27M | 264.30M | 189.27M | 206.10M | 181.39M | 185.86M | 206.48M | 41.75M | 255.15M | 231.36M | 310.23M | 184.09M | 200.66M | 261.82M | 255.02M |
| Diluted EPS | 1.74 | 2.11 | 2.46 | 2.75 | 2.46 | 1.84 | 1.99 | 1.75 | 1.81 | 2.00 | 0.39 | 2.44 | 2.25 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 |
| R&D Expense | 77.50M | 81.54M | 104.98M | 123.92M | 140.14M | 168.75M | 183.13M | 201.32M | 219.61M | 233.31M | 236.79M | 237.87M | 239.04M | 253.64M | 261.17M | 271.52M | 263.66M | 261.79M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.58B | 1.71B | 1.88B | 1.96B | 1.74B | 1.98B | 2.13B | 2.31B | 2.53B | 2.87B | 2.82B | 2.92B | 3.11B | 2.69B | 2.98B | 3.11B | 3.23B |
| Total Equity | 819.43M | 1.07B | 1.34B | 1.47B | 1.66B | 1.72B | 1.48B | 1.71B | 1.81B | 1.97B | 2.14B | 2.36B | 2.31B | 2.43B | 2.60B | 2.25B | 2.36B | 2.48B | 2.62B |
| Cash & Equivalents | 368.47M | 394.76M | 451.68M | 545.86M | 551.51M | 492.60M | 454.40M | 568.47M | 531.93M | 519.76M | 634.37M | 918.06M | 797.21M | 1.07B | 1.23B | 620.13M | 745.36M | 482.05M | 701.89M |
| Total Liabilities | - | - | 218.21M | 217.09M | 199.04M | 217.56M | 237.92M | 252.36M | 317.29M | 331.37M | 389.71M | 494.88M | 508.72M | 478.92M | 501.45M | 438.53M | 607.58M | 623.03M | 595.81M |
| Current Liabilities | - | - | 156.58M | 165.76M | 159.38M | 156.84M | 172.81M | 189.37M | 209.68M | 213.08M | 245.77M | 285.20M | 306.85M | 267.11M | 315.72M | 277.52M | 422.23M | 417.84M | 437.79M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 264.47M | 273.23M | 327.30M | 403.69M | 389.92M | 276.50M | 361.55M | 309.38M | 360.06M | 377.79M | 352.20M | 327.67M | 343.85M | 447.75M | 318.58M | 367.08M | 327.25M | 472.20M |
| Investing Cash Flow | -271.34M | -236.50M | -44.36M | -236.70M | -194.80M | 175.03M | -204.94M | -203.59M | -282.50M | -158.03M | 78.09M | -56.23M | 134.37M | -44.91M | -295.94M | 54.21M | -286.29M | -10.59M |
| Financing Cash Flow | 34.90M | 21.52M | -184.77M | -162.50M | -254.32M | -487.96M | -40.58M | -138.52M | -91.99M | -106.83M | -133.63M | -385.28M | -207.78M | -252.51M | -610.56M | -236.81M | -287.81M | -247.24M |
| Capital Expenditure | -13.61M | -13.99M | -37.48M | -47.36M | -167.35M | -26.71M | -75.36M | -157.53M | -100.76M | -99.62M | -72.81M | -96.28M | -66.35M | -54.45M | -47.93M | -30.34M | -30.01M | -36.35M |
| Free Cash Flow | 250.86M | 259.23M | 289.82M | 356.33M | 222.57M | 249.79M | 286.18M | 151.85M | 259.30M | 278.18M | 279.39M | 231.39M | 277.50M | 393.30M | 270.65M | 336.74M | 297.25M | 435.85M |
| Share Buybacks | - | - | 241.36M | 192.41M | 268.20M | 82.25M | 56.03M | 107.35M | 100.85M | 100.00M | 150.47M | 340.58M | 173.74M | 245.86M | 530.49M | 149.28M | 160.00M | 124.99M |
| Dividends Paid | - | - | - | 0 | 0 | 408.21M | 0 | 41.02M | 48.40M | 57.06M | 66.16M | 77.50M | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Sep 2008 | Sep 2009 | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 89.4% | 91.0% | 85.7% | 88.4% | 90.1% | 89.4% | 92.7% | 90.2% | 89.4% | 89.0% | 87.9% | 87.0% | 87.4% | 89.9% | 88.7% | 88.3% | 89.0% | 88.1% |
| Operating Margin % | 44.8% | 50.5% | 46.5% | 44.7% | 38.8% | 27.0% | 28.5% | 22.0% | 22.6% | 22.9% | 17.4% | 20.7% | 18.8% | 26.9% | 16.5% | 16.6% | 20.3% | 19.6% |
| Net Margin % | 31.2% | 33.8% | 30.7% | 32.2% | 28.3% | 20.8% | 21.5% | 18.7% | 18.1% | 19.1% | 4.0% | 20.5% | 19.9% | 24.2% | 14.7% | 15.4% | 20.6% | 18.9% |
| ROE % | 18.6% | 18.1% | 19.2% | 18.6% | 15.4% | 12.8% | 12.1% | 10.0% | 9.4% | 9.7% | 1.8% | 11.1% | 9.5% | 11.9% | 8.2% | 8.5% | 10.6% | 9.7% |
| ROCE % | - | 25.5% | 27.8% | 24.9% | 20.1% | 15.7% | 15.3% | 11.1% | 11.1% | 10.8% | 7.1% | 10.2% | 8.3% | 12.3% | 8.6% | 8.4% | 9.6% | 9.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 11.24% | 6.68M | $384.92M |
| 2 | Vanguard Portfolio Management LLC | 8.33% | 4.95M | $285.41M |
| 3 | Bank Of New York Mellon Corporation | 8.11% | 4.82M | $277.71M |
| 4 | Morgan Stanley | 7.74% | 4.60M | $265.29M |
| 5 | Vanguard Capital Management LLC | 4.58% | 2.72M | $156.92M |
| 6 | First Trust Advisors LP | 4.55% | 2.71M | $155.97M |
| 7 | State Street Corporation | 3.90% | 2.32M | $133.60M |
| 8 | Acadian Asset Management. LLC | 3.19% | 1.90M | $109.40M |
| 9 | Geode Capital Management, LLC | 3.10% | 1.84M | $106.20M |
| 10 | FMR, LLC | 2.67% | 1.59M | $91.41M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DLB
Dolby (DLB) Stock May Be 50% Undervalued As CEO Change Looms - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQa29DNmJvNVc3YS13YVRMR1gtZzE5M2wwRlIxdHZCN2FET2NqVldNWWZreDNoTlp4cDFjUkFYa2N1Rmw3WXRiZ0VmM0xETGpjbXNSM2RVUkk4YjZsZHZqVXdWWmlxRjVhSElzVVhYZ25WZTF1ckZqWE5jV1BIa2Y0SEotUGdUQjhGQkVDOW…
John Couling Sells 7,667 Shares of Dolby Laboratories (NYSE:DLB) Stock - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxONk1XZVoyaUYtQmRkSlRGV3loajNrT2pMVW1CSlpLMkI1dWlsVC1QTlBEM3lMS0g1NHV1d1RPVjliTV9pVTNMcnhFTVV5MFFIdnczY3VzelNSZzRxRi1pV0VnVVAtcW91b05BMndxZWNRSktJRXNnMHpDUHlHZ2xZcEpwZklWdEFaNklORj…
3 Reasons to Sell DLB and 1 Stock to Buy Instead - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQV3VYaTJVeVQtRG4tZDYwdUhhSFBnUFJ2c3JVZkFNTnJkRmdGNzhXbm4yWXpFTEtSYmh0MUlkX0h5Tkpzcjk3ODhoM1ZCekdfWkNTRVd1TVRBNzhycUNBV05sa0RJcWxONGlvbDd0ZkJMUnhQc2ExRXNGWElEM3dhZ3FZTm5Yajg3UGxVLX…
Dolby (DLB) Stock May Trade Below Fair Value While Earnings Look About Right - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE5ld0pUT2ZMU3hnXzZfZkMtcnRUWi1LS1g1NG9GS1JjQVdaMXFfbmZRTm1mOWxjZkV0cnA3MVdfMVVMdHJkRHFHMTZxVF9HUjhlLVRmQTZadkg?oc=5" target="_blank">Dolby (DLB) Stock May Trade Below Fair Value Whi…
Dolby (NYSE: DLB) exec trades 7,667 shares in 10b5-1 plan - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPcEN5b1dhdER2bWRhVXhmQ3h5Vkx3X24yc3kzSW1nUDB5c19UbWlSN2lkVTNHdTM2VGdxakU0T1JjTlNDdW1yaDZhdUJFcFdwdGFEbnJ6bDlDQ3BpdHduTG8yQ0lpUUE4LVJTN3BrRVUxQ01pZmF6QUxRR2NkV0s5MzkxRnRsR1kzZThOSn…
Why Dolby Laboratories (DLB) Stock Is Down Today - StockStory
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZDhWLWxmdjlKdHdNQ3FnVHZqMmFJeXZpRGI3Z1FhOE9RcHFhX3I4cUFldF9janlac3JHc3hCRXJWbk5mallCQnk5cUZQRnhWU3pOWWJpcFMtb1lUc1lFUnBYRFBxNWdWUEpHcnRfM0FmRW5mMElwMUVGYUtZb3FzNmprMzhUMjlNUTFpSG…
DLB — Frequently Asked Questions
What is the current share price of Dolby Laboratories, Inc. (DLB)?
As of 2026-09-19 21:16 PDT, Dolby Laboratories, Inc. (DLB) trades at $62.32 on NYSE. Its 52-week range is $48.23 to $73.91.
What is the market capitalisation of DLB?
Dolby Laboratories, Inc. (DLB) has a market capitalisation of $3.70B on NYSE.
What is the P/E ratio of DLB?
DLB trades at a trailing price-to-earnings (P/E) ratio of 26.52. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 2.24.
Does DLB pay a dividend?
Dolby Laboratories, Inc. (DLB) currently offers a dividend yield of 2.31%.
What is the return on equity (ROE) of DLB?
DLB has a return on equity (ROE) of 8.76%. Its return on capital employed (ROCE) is 9.50%.
Is DLB a good stock to buy?
This page provides a data-driven analysis of Dolby Laboratories, Inc. (DLB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.